Medicare ACO 

This information has been posted to meet regulatory requirements.

ACO Name and Location

Health Connect Partners
800 Fifth Ave. Suite 1200
Seattle, WA, USA 98104

ACO Primary Contact

Carolyn Schauble
Carolyn.Schauble@providence.org
206-628-2570

Organizational Information:


ACO Participants

  • Providence Health & Services - Washington
  • Providence Health & Services - Montana
  • Swedish Health Services
  • Swedish First Hill Diagnostic Imaging
  • Swedish Edmonds
  • Caron Corporation
  • Columbia Medical Group
  • Minor and James Medical
  • Pacific Medical Centers

ACO Participants in Joint Ventures between ACO Professionals and Hospitals:

No participants are involved in a joint venture between ACO professionals and hospitals.

ACO Governing Body

  • David Brown, Voting Member and Chair, Chief Executive Officer Health Connect Partners, LLC (ACO Participant, Providence Health & Services - Washington)
  • Dr. Rick Ludwig, Voting Member, Chief Medical Officer Health Connect Partners, LLC (ACO Participant, Providence Health & Services - Washington)
  • Dr. Jon Younger, Voting Member, Senior Medical Director Swedish Health Systems (ACO Participant, Providence Health & Services - Washington )
  • Dr. Thomas Yetman, Voting Member, Chief Executive Providence Physician Group (ACO Participant, Providence Health & Services - Washington)
  • Dr. Rik Emaus, Voting Member, Chief Executive Providence Physician Group (ACO Participant, Providence Health & Services - Washington)
  • Dr. Harold Johnston, Voting Member, Chief Executive Providence Medical Group Alaska, Providence Medical Group Alaska (ACO Participant, Providence Health & Services - Alaska)
  • Dr. Adam Smith, Voting Member, Chief of Staff and Family Practice Physician, Providence St. Joseph Medical Clinic (ACO Participant, Providence Health & Services - Montana)
  • Kelly Stanford, Voting Member, Vice President of Clinical Operations and Market Integration for Group Health Cooperative and President of CareUnity (ACO Participant, Columbia Medical Group)
  • Dr. Kirk Rowbotham, Voting member, Chief Medical Officer Physician Management Group Spokane (ACO Participant, Providence Health & Services - Washington)
  • Dr. Timothy Davidson, Voting Member, Chief Executive Physician (ACO Participant, Providence Health & Services - Washington)
  • Dr. James Martin, Voting Member, Chief Medical Officer, Minor and James Medical (ACO Participant, Minor and James Medical)
  • Scott Combs, Voting Member, Chief Financial Officer Pacific Medical Centers (ACO Participant, Pacific Medical Center)
  • Dr. Terry R. Rogers, Voting Member, Medicare beneficiary representative, CEO for the Foundation for Health Care Quality (Medicare beneficiary representative)
  • Craig Enge, Non-Voting Member, Chief Operating Officer Accountable Care Services
  • Laura Butcher, Non-Voting Member, Director Strategic Portfolio Management Health Connect Partners, LLC

Key ACO Clinical and Administrative Leadership:

  • Executive Officer: David Brown
  • Operations Officer: Laura Butcher
  • Medical Officer: Dr. Rick Ludwig
  • Finance Officer: Becky Williams
  • Communications Officer: Clay Holtzman
  • Compliance Officer: Kelly Robberson

Associated Committees and Committee Leaderships:

  • Model of Care Committee: Rick Ludwig, MD Chair
  • Operations, Analytics & Compliance Committee: Laura Butcher, Chair
  • Governing Body Compliance Committee: Carrie Smith, Chair
Health Connect Partners, LLC ACO Committees and Key Leadership Personnel

Types of ACO Participants or Combination of Participants that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital employing ACO professionals

Shared Savings and Losses


Amount of Shared Savings/Losses

  • Performance Year 2014: $0
  • Performance Year 2015: Not yet determined
  • Performance Year 2016: Not yet determined

How Shared Savings Are Distributed

  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care process/resources: 0%
  • Proportion of distribution to ACO participants: 100%

Quality Performance Results


Quality Performance Results Table

Measure Number

Performance Measure

2014 Reporting Period

ACO Performance Rate

Mean Performance Rate for All ACOs

ACO-1

Getting Timely Care, Appointments, and Information

81.79

80.13

ACO-2

How Well Your Doctors Communicate

92.46

92.39

ACO-3

Patients’ Rating of Doctor

90.47

91.58

ACO-4

Access to Specialists

86.23

83.97

ACO-5

Health Promotion and Education

53.12

58.29

ACO-6

Shared Decision Making

74.67

74.60

ACO-7

Health Status/Functional Status

69.66

71.10

ACO-8

Risk Standardized, All Condition Readmissions

14.42

15.15

ACO-9

ASC Admissions: COPD or Asthma in Older Adults

0.53

1.08

ACO-10

ASC Admission: Heart Failure

1.02

1.19

ACO-11

Percent of Primary Care Providers who Qualified for EHR Incentive Payment

84.83

76.71

ACO-12

Medication Reconciliation

34.34

82.61

ACO-13

Falls: Screening for Fall Risk

23.79

45.60

ACO-14

Influenza Immunization

60.98

57.51

ACO-15

Pneumococcal Vaccination

71.18

55.03

ACO-16

Adult Weight Screening and Follow-up

46.99

66.75

ACO-17

Tobacco Use Assessment and Cessation Intervention

93.30

86.79

ACO-18

Depression Screening

12.82

39.27

ACO-19

Colorectal Cancer Screening

54.81

56.14

ACO-20

Mammography Screening

63.83

61.41

ACO-21

Proportion of Adults who had blood pressure screened in past 2 years

50.24

60.24

Diabetes Composite

ACO –22-26

Diabetes Composite

31.63

25.41

ACO-22

Beneficiaries with diabetes who met of all the following criteria: Hemoglobin A1c Control (HbA1c) (<8 percent)

77.37

N/A

ACO-23

Beneficiaries with diabetes who met of all the following criteria: Low Density Lipoprotein (LDL) (< 100 mg/dL)

N/A

N/A

ACO-24

Beneficiaries with diabetes who met of all the following criteria: Blood Pressure (BP) < 140/90

76.16

 

N/A

ACO-25

Beneficiaries with diabetes who met of all the following criteria: Tobacco Non-Use

93.43

 

N/A

ACO-26

Beneficiaries with diabetes who met of all the following criteria: Aspirin Use

89.80

N/A

ACO-27

Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)

15.33

20.35

ACO-28

Percent of beneficiaries with hypertension whose BP < 140/90

66.07

68.02

ACO-29

Percent of beneficiaries with IVD with complete lipid profile and LDL control
< 100mg/dl

N/A

N/A

ACO-30

Percent of beneficiaries who use Aspirin or other antithrombotic

93.67

80.79

ACO-31

Beta-Blocker Therapy for LVSD

90.68

82.71

CAD Composite
ACO – 32-33

CAD Composite

58.15

N/A

ACO-32

Percent of beneficiaries with CAD who met all of the following criteria: Drug Therapy for Lowering LDL-Cholesterol

N/A

N/A

ACO-33

Percent of beneficiaries with CAD who met all of the following criteria: (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD)

70.32

N/A


For more information on how to interpret scores on the above quality performance measures, see http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf.